KEAP1 and vitiligo: This Keap1/NRF2/ARE axis is thus essential for maintaining cellular redox homeostasis and has been implicated as a promising therapeutic target in vitiligo, where enhanced NRF2 activity may counteract oxidative damage and melanocyte loss [11].